A Supreme Court ruling may have made it harder to get some info from the FDA

9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...

Read more →

Will transparent pricing make America’s health care cheaper?

29 June 2019 - A new executive order requires hospitals and insurers to disclose their negotiated prices. ...

Read more →

Drug price TV ad rule will cause consumer confusion, drug makers argue

2 July 2019 - Three drug makers on Monday urged a federal judge to block a new Trump administration rule ...

Read more →

Recommendations made by the PBAC - May 2019 intracycle meeting

28 June 2019 - The Department of Health has published an update of the outcomes from the May 2019 PBAC ...

Read more →

Trump administration defends rule requiring drug prices in TV ads

27 June 2019 - The Trump administration is urging a federal judge to allow a new rule to take effect ...

Read more →

FDA seeks public feedback on new drug approval transparency efforts

26 June 2019 - Today the U.S. FDA issued a Federal Register notice, New Drugs Regulatory Program Modernization: Improving Approval Package ...

Read more →

Why transparency on medical prices could actually make them go higher

24 June 2019 - It could depend on how much the health care system resembles the Danish concrete market. ...

Read more →

Trump Administration pushes to make health care pricing more transparent

24 June 2019 - President Trump signed an executive order Monday on price transparency in health care that aims to ...

Read more →

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

21 June 2019 - Merck Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government ...

Read more →

Price disclosure 2019 October cycle outcomes summary

21 June 2019 - The summary of price disclosure price reductions for the 2019 October Cycle has now been published on ...

Read more →

Statement on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs

18 June 2019 - The U.S. FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by ...

Read more →

Drug makers sue to block requirement for listing prices in TV ads

14 June 2019 - The rule, set to take effect 9 July, is one of the most visible efforts by the ...

Read more →

Should the FDA disclose new filings for drugs, biologics and biosimilars?

11 June 2019 - In 2010, the FDA issued draft recommendations on increasing the transparency of the FDA’s processes and ...

Read more →

Liberals rip Democratic leaders for writing drug pricing bill in secret

6 June 2019 - Progressive House Democrats are growing increasingly frustrated with their party’s leadership, accusing them of writing Democrats’ ...

Read more →

Hiding in plain sight: the FDA’s approach to disclosing new drug applications is a disservice to public health

4 June 2019 - Remember in high school when a friend told you a secret and you guarded it assiduously, ...

Read more →